S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Stock market today: Markets mostly higher after Biden-McCarthy deal on US debt
[Strong Buy Alert] Is this laser stock in your portfolio? (Ad)
10 Ways Entrepreneurs Can Navigate a Down Economy
PwC Australia sidelines 9 directors as leak of tax information investigated
3 Free Stock Picks per Day (Ad)
South African president appoints judge to oversee weapons-for-Russia inquiry
Drought-struck Barcelona quenches thirst with costly desalination
3 Free Stock Picks per Day (Ad)
Poland imposes sanctions on 365 Belarusians over 'draconian' verdict against journalist
North Korea notifies neighboring Japan it plans to launch satellite in coming days
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Stock market today: Markets mostly higher after Biden-McCarthy deal on US debt
[Strong Buy Alert] Is this laser stock in your portfolio? (Ad)
10 Ways Entrepreneurs Can Navigate a Down Economy
PwC Australia sidelines 9 directors as leak of tax information investigated
3 Free Stock Picks per Day (Ad)
South African president appoints judge to oversee weapons-for-Russia inquiry
Drought-struck Barcelona quenches thirst with costly desalination
3 Free Stock Picks per Day (Ad)
Poland imposes sanctions on 365 Belarusians over 'draconian' verdict against journalist
North Korea notifies neighboring Japan it plans to launch satellite in coming days
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Stock market today: Markets mostly higher after Biden-McCarthy deal on US debt
[Strong Buy Alert] Is this laser stock in your portfolio? (Ad)
10 Ways Entrepreneurs Can Navigate a Down Economy
PwC Australia sidelines 9 directors as leak of tax information investigated
3 Free Stock Picks per Day (Ad)
South African president appoints judge to oversee weapons-for-Russia inquiry
Drought-struck Barcelona quenches thirst with costly desalination
3 Free Stock Picks per Day (Ad)
Poland imposes sanctions on 365 Belarusians over 'draconian' verdict against journalist
North Korea notifies neighboring Japan it plans to launch satellite in coming days
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Stock market today: Markets mostly higher after Biden-McCarthy deal on US debt
[Strong Buy Alert] Is this laser stock in your portfolio? (Ad)
10 Ways Entrepreneurs Can Navigate a Down Economy
PwC Australia sidelines 9 directors as leak of tax information investigated
3 Free Stock Picks per Day (Ad)
South African president appoints judge to oversee weapons-for-Russia inquiry
Drought-struck Barcelona quenches thirst with costly desalination
3 Free Stock Picks per Day (Ad)
Poland imposes sanctions on 365 Belarusians over 'draconian' verdict against journalist
North Korea notifies neighboring Japan it plans to launch satellite in coming days
NYSE:OMI

Owens & Minor (OMI) Price Target & Analyst Ratings

$20.35
+0.45 (+2.26%)
(As of 05/26/2023 07:00 PM ET)
Compare
Today's Range
$19.80
$20.49
50-Day Range
$4.15
$20.89
52-Week Range
$11.79
$37.03
Volume
401,800 shs
Average Volume
921,622 shs
Market Capitalization
$1.55 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$18.83

Owens & Minor Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Hold
Based on 5 Analyst Ratings

Consensus Analyst Price Target

$18.83
-7.45% Downside
High Prediction$24.00
Average Prediction$18.83
Low Prediction$17.00
TypeCurrent
5/29/22 to 5/29/23
1 Month Ago
4/29/22 to 4/29/23
3 Months Ago
2/28/22 to 2/28/23
1 Year Ago
5/29/21 to 5/29/22
Consensus Rating
Hold
Hold
Hold
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
0 Buy rating(s)
0 Buy rating(s)
0 Buy rating(s)
1 Buy rating(s)
Hold
3 Hold rating(s)
3 Hold rating(s)
3 Hold rating(s)
1 Hold rating(s)
Sell
2 Sell rating(s)
2 Sell rating(s)
2 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$18.83$17.20$19.20$50.50
Predicted Upside-7.45% Downside15.48% Upside7.04% Upside23.96% Upside
Get Owens & Minor Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for OMI and its competitors with MarketBeat's FREE daily newsletter.


OMI Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

OMI Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Owens & Minor Stock vs. The Competition

TypeOwens & MinorMedical CompaniesS&P 500
Consensus Rating Score
1.60
2.66
2.48
Consensus RatingHoldBuyHold
Predicted Upside-7.45% Downside1,318.29% Upside196.76% Upside
News Sentiment RatingPositive News
Positive News
Positive News

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
5/8/2023UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$22.00 ➝ $24.00+28.82%
5/8/2023Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$18.00 ➝ $21.00+12.72%
3/8/2023Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral$20.00 ➝ $17.00+17.24%
3/7/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral$20.00 ➝ $17.00+17.24%
10/12/2022Bank Of America (Bofa)
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Michael Cherny
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Underperform$43.00 ➝ $17.00+12.66%
10/12/2022Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Underperform$43.00 ➝ $17.00+12.96%
(Data available from 5/29/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












OMI Price Target - Frequently Asked Questions

What is Owens & Minor's consensus rating and price target?

According to the issued ratings of 5 analysts in the last year, the consensus rating for Owens & Minor stock is Hold based on the current 2 sell ratings and 3 hold ratings for OMI. The average twelve-month price prediction for Owens & Minor is $18.83 with a high price target of $24.00 and a low price target of $17.00. Learn more on OMI's analyst rating history.

Do Wall Street analysts like Owens & Minor more than its competitors?

Analysts like Owens & Minor less than other Medical companies. The consensus rating for Owens & Minor is Hold while the average consensus rating for medical companies is Buy. Learn more on how OMI compares to other companies.

Does Owens & Minor's stock price have much upside?

According to analysts, Owens & Minor's stock has a predicted upside of 21.24% based on their 12-month price targets.

What analysts cover Owens & Minor?

Owens & Minor has been rated by Citigroup, Credit Suisse Group, Robert W. Baird, and UBS Group in the past 90 days.


Stock Ratings Reports and Tools

This page (NYSE:OMI) was last updated on 5/29/2023 by MarketBeat.com Staff

My Account -